A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens

The Journal of Nervous and Mental Disease
Brian S BarnettHarrison G Pope

Abstract

Recent years have seen renewed interest and research about the use of hallucinogens as possible agents in the treatment of psychiatric disorders. However, we are unaware of studies assessing the current attitudes of American psychiatrists regarding hallucinogens. Therefore, we e-mailed surveys to 1000 members of the American Psychiatric Association-250 resident-fellows and 750 attending psychiatrists. The response rate was 32.4%. Respondents tended to perceive hallucinogens as potentially hazardous and appropriately illegal for recreational purposes. However, a large minority expressed optimism about the potential use of hallucinogens for psychiatric treatment. Male and trainee respondents, as compared with female and attending respondents, reported less concern about the risks of hallucinogens and greater optimism about their therapeutic potential. Younger psychiatrists also seemed more optimistic. Optimism among trainees and younger psychiatrists may possibly reflect greater exposure to recent positive publications about hallucinogens and less awareness of more negative past reports.

References

Jan 1, 1985·Statistics in Medicine·J Cuzick
Oct 1, 1984·The Journal of Nervous and Mental Disease·R J Strassman
Nov 1, 1995·American Journal of Epidemiology·D A Savitz, A F Olshan
Mar 1, 1995·The Journal of Nervous and Mental Disease·R J Strassman
Jun 19, 2002·BMC Medical Research Methodology·Ronald J Feise
Jan 1, 1959·Maryland State Medical Journal·I D YALOM
Jan 1, 1960·The Journal of Nervous and Mental Disease·S COHEN
Nov 8, 2005·Biological Psychiatry·John H HalpernHarrison G Pope
Sep 8, 2010·Archives of General Psychiatry·Charles S GrobGeorge R Greer
Dec 12, 2012·Journal of Addiction Medicine·Christian BlachaCarlos Schönfeldt-Lecuona
Aug 27, 2013·PloS One·Teri S Krebs, Pål-Ørjan Johansen
Mar 7, 2014·The Journal of Nervous and Mental Disease·Peter GasserRudolf Brenneisen
Jan 15, 2015·Journal of Psychopharmacology·Michael P BogenschutzRick J Strassman
Mar 7, 2015·Journal of Psychopharmacology·Pål-Ørjan Johansen, Teri Suzanne Krebs
May 24, 2016·The Lancet. Psychiatry·Robin L Carhart-HarrisDavid J Nutt
Jul 22, 2016·The American Journal of Drug and Alcohol Abuse·Matthew W JohnsonRoland R Griffiths

❮ Previous
Next ❯

Citations

Apr 3, 2019·Reviews in the Neurosciences·Noemi Császár-NagyIstván Bókkon
Apr 14, 2021·Journal of Palliative Medicine·Yvan BeaussantUNKNOWN Radcliffe Institute for Advanced Study Working Group on Psychedelic Research in Serious Illness
Jun 17, 2021·Irish Journal of Medical Science·Kate CorriganJohn R Kelly
Jul 3, 2021·Journal of the Academy of Consultation-Liaison Psychiatry·Brian S Barnett, George R Greer
Jul 31, 2021·Frontiers in Psychology·Sascha B ThalPetra M Skeffington
Aug 8, 2021·International Journal of Environmental Research and Public Health·Lisa M ReynoldsWilliam J Evans
Jan 5, 2022·Journal of Psychoactive Drugs·Brianna R AltmanJoseph De Leo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.